Novavax, Inc.
METHODS FOR PREVENTING DISEASE OR DISORDER CAUSED BY RSV INFECTION

Last updated:

Abstract:

The present invention is generally related to modified or mutated respiratory syncytial virus (RSV) fusion (F) proteins and methods for making and using them, including immunogenic compositions such as vaccines for the treatment and/or prevention of RSV infection. Specifically, the disclosure provides a method of maternal immunization comprising administering a composition comprising an RSV F protein and an adjuvant to a pregnant woman carrying a gestational infant, wherein the method induces an immune response against at least one symptom associated with RSV lower respiratory tract infection (LRTI) in the infant following birth.

Status:
Application
Type:

Utility

Filling date:

25 Feb 2020

Issue date:

5 May 2022